Oxytocin on Approach Bias and Craving
Key facts
- Who runs it
- Jennifer Mitchell
- Where
- Berkeley, United StatesSee the site
- Trial code
- Status
- Withdrawn
- Phase
- Phase 2
- Started
- 1 Nov 2023
- Ended
- 20 Apr 2024
- Type of study
- Interventional, 2 groups
- Treatments tested
- Oxytocin
- Placebo
- Record updated
- 6 June 2022
- Why it stopped
- COVID made study visits impossible during the funding period.
Who can take part
- Age
- 21 years to 40 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 29 criteriaShow less
Who can take part
- Healthy volunteers who are 21-40 years of age
- If female, 10 or more alcoholic drinks must be consumed weekly
- If male, 14 or more alcoholic drinks must be consumed weekly
- Meets DSM-V criteria for Alcohol Use Disorder (AUD)
- Score 8 or greater on the Alcohol Use Disorders Identification Test (AUDIT)
- If female, must be non-lactating, not pregnant, and using a reliable contraception method (i.e. abstinence, intrauterine device [IUD], hormonal birth control, or barrier method)
- Native English speaker
- Right handed
- High school graduate or equivalent
- Able and willing to provide an informed consent
- Able to understand and follow the instructions of the investigator
Who cannot take part
- Positive urine drug screen (except marijuana)
- Using cocaine, stimulants (other than nicotine and caffeine), amphetamines, hallucinogens, ecstasy, opiates, sedatives, pain pills, sleeping pills, or other psychoactive drugs within 2 weeks of the start of the study (except marijuana)
- Current enrollment in an alcohol, or other drug treatment program or current legal problems relating to alcohol, or other drug use
- Has received an investigational drug within 30 days of Screening Visit
- History of major alcohol related complications within the preceding 2 years (liver failure/cirrhosis, pancreatitis, esophageal varices, etc.)
- Has a history of atrophic rhinitis, recurrent nose bleeds, cranial surgical procedures, hypophysectomy, chronic congestion, or sinus problems
- Has a history of cardiac arrhythmia
- Clinically significant medical or psychiatric illness requiring treatment as determined by screening blood tests, medical history, and/or physical exam performed or reviewed by the study physician
- Has a neurological dysfunction or psychiatric disorder (confirm with study physician)
- Has a history of brain trauma (confirm with study physician)
- Has an allergy or intolerance to oxytocin
- Has a history of claustrophobia
- SGPT/ALT or SGOT/AST values greater than 2x upper limit of normal
- Marijuana use more than 3 times/week
- Currently trying to quit alcohol use
- Severely low blood (< 90/50) pressure or uncontrolled high blood pressure (>160/100)
- BAC level > 0.00% at the beginning of screening visit (within margin of error of detection)
- Has any MRI scanning contraindications
Where in United States
- University of California, San FranciscoBerkeley, United States
About the trial
What the trial wants to find out
This will be a laboratory-based investigation of the behavioral and neural effects of intranasal oxytocin on craving for alcohol and approach bias in moderate to heavy alcohol using subjects. This study uses a within-subject, randomized, placebo-controlled, counterbalanced, crossover design to compare the effects oxytocin and placebo. In this way, all subjects will be scanned twice; once following oxytocin administration and once following placebo administration, and will complete a series of behavioral tasks (both in and out of the scanner) at both visits.
The 2 groups in the trial
- Oxytocin FirstTreatment being tested
Subjects will receive oxytocin prior to their first scanning session, and placebo prior to their second scanning session.
Treatment: Oxytocin and Placebo
- Placebo FirstTreatment being tested
Subjects will receive placebo prior to their first scanning session, and oxytocin prior to their second scanning session.
Treatment: Oxytocin and Placebo
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- The Effects of Intranasal Oxytocin on Approach Bias and Craving in Moderate to Heavy Alcohol Drinkers
- Record updated
- 6 June 2022